Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to -$1.7 billion.

  • Ironwood Pharmaceuticals' Retained Earnings rose 167.94% to -$1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 billion, marking a year-over-year increase of 167.94%. This contributed to the annual value of -$1.7 billion for FY2024, which is 5.18% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Retained Earnings stood at -$1.7 billion, which was up 167.94% from -$1.7 billion recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Retained Earnings ranged from a high of -$650.7 million in Q1 2023 and a low of -$1.7 billion during Q1 2025
  • For the 5-year period, Ironwood Pharmaceuticals' Retained Earnings averaged around -$1.3 billion, with its median value being -$1.7 billion (2025).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Retained Earnings surged by 4161.54% in 2022, and later crashed by 16169.92% in 2024.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Retained Earnings stood at -$937.6 million in 2021, then grew by 25.73% to -$696.4 million in 2022, then plummeted by 143.92% to -$1.7 billion in 2023, then grew by 0.05% to -$1.7 billion in 2024, then increased by 1.55% to -$1.7 billion in 2025.
  • Its Retained Earnings was -$1.7 billion in Q3 2025, compared to -$1.7 billion in Q2 2025 and -$1.7 billion in Q1 2025.